PPARG and cancer: In the multivariate Cox regression analysis, the use of PPAR‐γ activating ARBs remained statistically significantly associated with a reduction in all‐cause mortality and disease progression after adjusting for potential confounders including age, sex, and cancer stage (Table S5).